Literature DB >> 20464151

[Mortality due to visceral leishmaniasis: clinical and laboratory characteristics].

Janaina Michelle de Oliveira1, Ana Claudia Fernandes, Maria Elizabeth Cavalheiros Dorval, Túlia Peixoto Alves, Thiago Dias Fernandes, Elisa Teruya Oshiro, Ana Lúcia Lyrio de Oliveira.   

Abstract

INTRODUCTION: Visceral leishmaniasis is a systemic infectious disease of broad geographical distribution, characterized by high potential for lethality. With the purpose of contributing towards reducing mortality and helping healthcare professionals in clinical management of patients with this disease, this paper aimed to investigate the clinical and laboratory characteristics of cases with a fatal outcome in hospitals in Campo Grande, Mato Grosso do Sul, between 2003 and 2008.
METHODS: Fifty-five medical files on patients who died due to visceral leishmaniasis were analyzed.
RESULTS: Among the 55 patients studied, 37 were from the municipality of Campo Grande; 41 (74.5%) were males; and age over 40 years predominated. The patients presented with fever in 89.1% of the cases. The duration of the illness from the onset of symptoms to hospitalization was 78.2 days on average. Leukopenia was seen in 85.5% of the patients. Comorbidities were present in 39 (70.9%) patients; malnutrition and alcoholism were the most frequent of these. Confirmation of the diagnosis occurred on average 6.7 days after admission. Pentavalent antimoniate was the drug most used, and 87.5% of the patients presented some type of adverse reaction. Bacterial infections occurred in 36 patients and were one of the causes of death in 27 (49%).
CONCLUSIONS: The data showed that early identification of these clinical and laboratory characteristics, at the time when patients are first attended, is extremely important for reducing mortality through instituting efficient therapeutic and prophylactic measures.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20464151     DOI: 10.1590/s0037-86822010000200016

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  20 in total

1.  Asymptomatic Visceral Leishmania infantum Infection in US Soldiers Deployed to Iraq.

Authors:  Rupal M Mody; Ines Lakhal-Naouar; Jeffrey E Sherwood; Nancy L Koles; Dutchabong Shaw; Daniel P Bigley; Edgie-Mark A Co; Nathanial K Copeland; Linda L Jagodzinski; Rami M Mukbel; Rebecca A Smiley; Robert C Duncan; Shaden Kamhawi; Selma M B Jeronimo; Robert F DeFraites; Naomi E Aronson
Journal:  Clin Infect Dis       Date:  2019-05-30       Impact factor: 9.079

2.  Late diagnosis: a factor associated with death from visceral leishmaniasis in elderly patients.

Authors:  Marta Driemeier; Polliana Alvarenga de Oliveira; Angelita Fernandes Druzian; Laís Ferreira Lopes Brum; Elenir Rose Jardim Cury Pontes; Maria Elizabeth Cavalheiros Dorval; Anamaria Mello Miranda Paniago
Journal:  Pathog Glob Health       Date:  2015-08-10       Impact factor: 2.894

3.  American visceral leishmaniasis: factors associated with lethality in the state of são paulo, Brazil.

Authors:  Geraldine Madalosso; Carlos Magno Fortaleza; Ana Freitas Ribeiro; Lisete Lage Cruz; Péricles Alves Nogueira; José Angelo Lauletta Lindoso
Journal:  J Trop Med       Date:  2012-09-13

4.  Immunodominant antigens of Leishmania chagasi associated with protection against human visceral leishmaniasis.

Authors:  Daniel R Abánades; Leonardo V Arruda; Elaine S Arruda; José Roberto A S Pinto; Mario S Palma; Dorlene Aquino; Arlene J Caldas; Manuel Soto; Aldina Barral; Manoel Barral-Netto
Journal:  PLoS Negl Trop Dis       Date:  2012-06-19

5.  Early clinical manifestations associated with death from visceral leishmaniasis.

Authors:  Valdelaine Etelvina Miranda de Araújo; Maria Helena Franco Morais; Ilka Afonso Reis; Ana Rabello; Mariângela Carneiro
Journal:  PLoS Negl Trop Dis       Date:  2012-02-07

6.  Risk Factors for Death from Visceral Leishmaniasis in an Urban Area of Brazil.

Authors:  Angelita F Druzian; Albert S de Souza; Diogo N de Campos; Julio Croda; Minoru G Higa; Maria Elizabeth C Dorval; Mauricio A Pompilio; Polliana A de Oliveira; Anamaria M M Paniago
Journal:  PLoS Negl Trop Dis       Date:  2015-08-14

7.  Historical series of patients with visceral leishmaniasis treated with meglumine antimoniate in a hospital for tropical diseases, Maceió-AL, Brazil.

Authors:  Lindon Johoson Diniz Silveira; Thiago José Matos Rocha; Sandra Aparecida Ribeiro; Célia Maria Silva Pedrosa
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Jan-Feb       Impact factor: 1.846

8.  Leishmania-HIV co-infection: clinical presentation and outcomes in an urban area in Brazil.

Authors:  Gláucia F Cota; Marcos R de Sousa; Andrea Laender Pessoa de Mendonça; Allan Patrocinio; Luiza Siqueira Assunção; Sidnei Rodrigues de Faria; Ana Rabello
Journal:  PLoS Negl Trop Dis       Date:  2014-04-17

9.  Mortality and case fatality due to visceral leishmaniasis in Brazil: a nationwide analysis of epidemiology, trends and spatial patterns.

Authors:  Francisco Rogerlândio Martins-Melo; Mauricélia da Silveira Lima; Alberto Novaes Ramos; Carlos Henrique Alencar; Jorg Heukelbach
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

10.  Spatial distribution and environmental factors associated to phlebotomine fauna in a border area of transmission of visceral leishmaniasis in Mato Grosso do Sul, Brazil.

Authors:  Ana Rachel Oliveira de Andrade; Baldomero Antonio Kato da Silva; Geucira Cristaldo; Sonia Maria Oliveira de Andrade; Antonio Conceição Paranhos Filho; Alisson Ribeiro; Mirella Ferreira da Cunha Santos; Renato Andreotti
Journal:  Parasit Vectors       Date:  2014-06-04       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.